Download PDF
CC BY-NC-ND 4.0 · Annals of Otology and Neurotology 2020; 3(02): 047-056
DOI: 10.1055/s-0041-1724220
Review Article

Role of Free Radicals, Glutamate Toxicity, Glutathione Depletion in Apoptosis of Cochlear Hair Cells, Neuronal Cells among Patients with Sensorineural Hearing Loss

Vithal D. Udagatti
1   N.R.M ENT Hospital, Raichur, Karnataka, India
,
Rajendran Dinesh Kumar 
2   Rajarajeswari Medical College and Hospital, Department of ENT and Head-Neck Surgery, Bengaluru, Karnataka, India
,
Arjunsing Vijaysing Samorekar
2   Rajarajeswari Medical College and Hospital, Department of ENT and Head-Neck Surgery, Bengaluru, Karnataka, India
,
Vaibhavi KR
2   Rajarajeswari Medical College and Hospital, Department of ENT and Head-Neck Surgery, Bengaluru, Karnataka, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction Hearing loss may lead to depression, decreased quality of life, reduced functional status and social isolation. The glutathione-S transferase (GSTS) is an antioxidant scavenging enzyme. Decreased glutathione and GSTS activity levels lead to an increase in susceptibility of hair-cell damage leading to sensorineural hearing loss. The cumulative effect of oxidative stress and mitochondrial damage by free radicals results in the mutation/deletion of deoxyribonucleic acid, leading to decline in mitochondrial function, which in turn plays an important role in inducing apoptosis of the cochlear cells. Other risk factors also include noise exposure, genetic predisposition, health comorbidities, ototoxic drugs, infections, and immune-mediated inflammation of auditory cells.

Study Design Prospective, non-comparative, metacentric clinical study.

Materials and Methods The study was carried out in 30 patients from 6/5/2016 to 10/1/2018. Total of 30 patients of sensorineural hearing loss were enrolled (17 males, 13 females). Clinical history, ENT examination, and audiogram were done, treatment duration of 8 weeks for each patient and followed up to 3 outpatient visits. The patient was administered rebamipide 100 mg, alpha lipoic acid 100 mg, and acetylcysteine 100 mg capsules twice a day for a total period of 8 weeks. Wherever giddiness was an added symptom, Cinnarizine 20mg with Diaminehydrate 40 mg combination twice a day was added up to complete relief of symptoms, thereafter once a day as maintenance dose over a period of 8 weeks. Wherever tinnitus was an added symptom, deflazacort 6 mg twice a day was added and tapered up to 1 month. If the symptom of tinnitus persisted, intratympanic steroid injection was given. During every visit, clinical assessment and audiogram were repeated.

Results Our study demonstrated greater improvement in hearing at higher frequencies with 8 weeks of rebamipide 100 mg + alpha lipoic acid 100 mg + acetylcysteine 100 mg administration in 30 patients with twice-daily dosing.

Conclusion Synthesis of free radicals in the inner ear may play an important part in the pathogenesis of sensory hearing loss. The combination of rebamipide 100 mg + alpha lipoic acid 100 mg + acetylcysteine 100 mg is effective prophylaxis in sensorineural hearing loss that addresses both factors of inhibiting the cochlear cell damage and enhancing cochlear cell preservation.

Keywords

presbyacusis - glutathione - sensorineural hearing loss - free radicals


Publication History

Article published online:
10 March 2021

© 2021. Indian Society of Otology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Yamasoba T, Lin FR, Someya S, Kashio A, Sakamoto T, Kondo K. Current concepts in age-related hearing loss: epidemiology and mechanistic pathways. Hear Res 2013; 303: 30-38
    CrossrefPubMedGoogle Scholar
  • 2 Wong AC, Ryan AF. Mechanisms of sensorineural cell damage, death and survival in the cochlea. Front Aging Neurosci 2015; 7: 58
    PubMedGoogle Scholar
  • 3 Fujimoto C, Yamasoba T. Oxidative stresses and mitochondrial dysfunction in age-related hearing loss. Oxid Med Cell Longev 2014; 2014: 582849
    CrossrefPubMedGoogle Scholar
  • 4 Bridgwood A. General Household Survey: Living in Britain—Results from the 1998 General Household Survey. London: The Stationery Office Books 2000
  • 5 Walling AD, Dickson GM. Hearing loss in older adults. Am Fam Physician 2012; 85 (12) 1150-1156
    PubMedGoogle Scholar
  • 6 Hyman LH. Hyman's Comparative Vertebrate Anatomy. 3rd edition. University of Chicago Press 1992: 634 ISBN: 0-226-87013-8
  • 7 Guyton Aurthur C, Hall John E. The Sense of Hearing. In: Textbook of Medical Physiology. 11th edition. chapter 52, Saunders Co. 2005: 657-658
  • 8 Merchant SN, Nadol Jr JB. Schuknecht's Pathology of the Ear. 3rd edition. Vol. 942. Shelton, People's Medical Publishing House 2010: 142-147
  • 9 Schuknecht HF, Gacek MR. Cochlear pathology in presbycusis. Ann Otol Rhinol Laryngol 1993; 102 (1 Pt 2) 1-161
    CrossrefPubMedGoogle Scholar
  • 10 Wright A, Forge A, Kotecha B. Ototoxicity. In: Booth JB, eds. Scott Browns Otolaryngology. Vol. 3. Otology. Oxford: Butterworth Heinemann 1997: 3/20/1–2/20/31
  • 11 Prasad KN, Cole WC, Prasad KC. Risk factors for Alzheimer’s disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Am Coll Nutr 2002; 21 (06) 506-522
    CrossrefPubMedGoogle Scholar
  • 12 Prasad KN. Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies. Expert Rev Anticancer Ther 2003; 3 (06) 903-915
    CrossrefPubMedGoogle Scholar
  • 13 Gates GA, Couropmitree NN, Myers RH. Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg 1999; 125 (06) 654-659
    CrossrefPubMedGoogle Scholar
  • 14 Ensink RJ, Camp GV, Cremers CW. Mitochondrial inherited hearing loss. Clin Otolaryngol Allied Sci 1998; 23 (01) 3-8
    CrossrefPubMedGoogle Scholar
  • 15 Waly MI, Al-Attabi Z, Guizani N. Low nourishment of vitamin C induces glutathione depletion and oxidative stress in healthy young adults. Prev Nutr Food Sci 2015; 20 (03) 198-203
    CrossrefPubMedGoogle Scholar
  • 16 Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 2003; 24 (04) 572-575
    CrossrefPubMedGoogle Scholar
  • 17 Kim HK, Kim JI, Kim JK. et al. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig Dis Sci 2007; 52 (08) 1776-1782
    CrossrefPubMedGoogle Scholar
  • 18 Matysiak-Budnik T, Heyman M, Mégraud F. Review article: rebamipide and the digestive epithelial barrier. Aliment Pharmacol Ther 2003; 18 (01) Suppl 1) 55-62
    CrossrefPubMedGoogle Scholar
  • 19 Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician 2009; 80 (03) 265-269
    PubMedGoogle Scholar
  • 20 Food and Drug Adminstration. (2006). Brian Harvey. Acetadote Package Insert. [PDF]. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021539s004lbl.pdf. Accessed January 10, 2020
  • 21 Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009; 1790 (10) 1149-1160
    CrossrefPubMedGoogle Scholar
  • 22 Howarth A, Shone GR. Ageing and the auditory system. Postgrad Med J 2006; 82 (965) 166-171
    CrossrefPubMedGoogle Scholar
  • 23 Allen JD. Human physiology - the basis of medicine. Ulster Med J 2008; 77 (03) 216
    Google Scholar
  • 24 Ruel J, Chabbert C, Nouvian R. et al. Salicylate enables cochlear arachidonic-acid-sensitive NMDA receptor responses. J Neurosci 2008; 28 (29) 7313-7323
    CrossrefPubMedGoogle Scholar